Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 12.9B | 13.9B | 13.4B | 12.9B |
Cost of revenue | 5.1B | 5.3B | 5.8B | 4.6B |
Gross profit | 7.8B | 8.6B | 7.6B | 8.3B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 7.9B | -2.4B | 7.6B | 8.1B |
Other operating expenses | — | — | — | — |
Operating income | 7.8B | 629.4M | 69.6M | 156.4M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | -181.9M | 766.2M | -2.5M | 329.0M |
Tax provision | -17.7M | 105.2M | -175.4M | 57.1M |
Net income | -164.2M | 661.0M | 173.0M | 271.9M |
Basic EPS | -14.1 | — | 15 | 23 |
Diluted EPS | -14.1 | — | 15 | 23 |
Basic average shares | — | — | 11.5M | 11.8M |
Diluted average shares | — | — | 11.5M | 11.8M |
EBITDA | 7.8B | 2.0B | 721.9M | 792.1M |
Net income from continuing op. | — | 661.0M | 173.0M | 271.9M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |